DNA Topoisomerases in Cancer Therapy

Present and Future

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Health & Well Being, Medical, Specialties, Oncology
Cover of the book DNA Topoisomerases in Cancer Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461501411
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461501411
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

More books from Springer US

Cover of the book Molecular Mechanisms of Programmed Cell Death by
Cover of the book Computer Graphics by
Cover of the book Targeting of Drugs 6 by
Cover of the book Proceedings of the European Computing Conference by
Cover of the book An Introduction to Mathematical Epidemiology by
Cover of the book Transformation from Wall Street to Wellbeing by
Cover of the book Perinatal Epidemiology for Public Health Practice by
Cover of the book Cell Biology of Extracellular Matrix by
Cover of the book New Trends in Cancer for the 21st Century by
Cover of the book Trends and Prospects in Metacognition Research by
Cover of the book Pension Reform in Latin America and Its Lessons for International Policymakers by
Cover of the book International Standardisation of Good Corporate Governance by
Cover of the book Indicators of Environmental Quality by
Cover of the book Intrinsic Motivation and Self-Determination in Human Behavior by
Cover of the book Cardiac Arrhythmias: New Therapeutic Drugs and Devices by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy